Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

23 Jul 2021 15:21

RNS Number : 3444G
Unicorn AIM VCT PLC
23 July 2021
 

 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 April 2021 to 30 June 2021

 

Introduction

 

This voluntary Interim Management Statement (IMS) covers the three month period ended 30 June 2021, together with relevant information up to the date of publication. 

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance  

The Company's portfolio of investments performed reasonably well with net asset value per share continuing to increase steadily over the quarter.

As at 30 June 2021, the unaudited net asset value was 247.6 pence per share, which represents an increase of +6.7% on the audited closing net asset value of 232.1 pence per share as at 31 March 2021. UK equity indices also continued their strong run, with the FTSE AIM All-Share Index generating a total return of +4.5%, while the FTSE All-Share Index delivered a total return of +5.6% over the same period.

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). A good number of these investee companies are relatively mature and, as such, most of these businesses have remained profitable, despite the difficulties posed by the ongoing COVID-19 pandemic.

The number and value of new VCT qualifying investments completed in the period was healthy and the pipeline of promising opportunities continues to strengthen. As a result, all key HMRC tests continue to be met. At the period end, an estimated 86.6% of total assets (assessed in accordance with VCT rules) was invested in VCT qualifying companies.

Despite the increased risks associated with early stage investment and the uncertainty created by the COVID-19 pandemic, the Investment Manager is confident that the portfolio, as a whole, has the potential to continue delivering attractive total returns over the longer term.

 

Material Transactions

During the period under review, four new VCT qualifying investments were completed, costing £9.2 million in total. One follow-on VCT qualifying investment was also made at a total cost of £0.5m.

Approximately £0.3 million was raised from the partial disposal of two holdings during the period. In addition, the Company's entire holding in Wey Education was sold, following a successful takeover bid from Inspired Education Group. This disposal realised proceeds of over £4.6 million and a capital profit of almost £2.5 million.

The purpose of disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to Shareholders via dividend payments, and to help manage liquidity requirements.

Top Ten VCT Qualifying Holdings as at 30 June 2021

Stock

% of fund

 

 

Interactive Investor

10.2%

Hasgrove

9.1%

Maxcyte

6.0%

Abcam

4.4%

Tracsis

4.1%

Renalytix AI

3.5%

Anpario

3.2%

Surface Transforms

3.0%

Tristel

2.8%

Augean

2.4%

 

 

Total

48.7%

 

Share Buy-Backs

 

During the period from 1 April to 30 June 2021, the Company bought back 592,273 of its own Ordinary Shares for cancellation, at a price of 210 pence per share. As at 30 June 2021, there were 149,758,626 Ordinary Shares in issue. After the period end, a further 293,191 Ordinary Shares were purchased for cancellation at a price of 215 pence per share.

 

Interim Dividend

As previously advised, the Board declared an interim dividend of 3.0 pence per share in respect of the Company's half year ended 31 March 2021. This interim dividend will be paid on 12 August 2021 to Shareholders who were on the register on 15 July 2021.

Issue of Equity

 

During the period, a total of 1,129,286 new Ordinary Shares were issued in the new tax year at prices ranging between 237.4p and 238.2p per share under the Offer for Subscription, which launched on 28 January 2021. The Offer closed on 11 February 2021 having raised approximately £15 million before costs.

Material Events

There were no material events during the period under review.

Chris Hutchinson

Director, Unicorn Asset Management

Investment Manager

 

23 July 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRMZGZNDFRGMZM
Date   Source Headline
5th Jun 20261:06 pmRNSNet Asset Value(s)
1st Jun 202610:50 amRNSTotal Voting Rights
20th May 202610:06 amRNSIssue of Equity
15th May 202610:33 amRNSAppointment of Director
6th May 20262:01 pmRNSNet Asset Value(s)
1st May 202610:07 amRNSTotal Voting Rights
1st Apr 20264:20 pmRNSNet Asset Value(s)
1st Apr 20268:22 amRNSTotal Voting Rights
12th Mar 20267:00 amRNSOffer for Subscription Update - Overallotment
10th Mar 20265:10 pmRNSTransaction in Own Shares
10th Mar 20265:10 pmRNSTransaction in Own Shares
6th Mar 20267:00 amRNSIssue of Equity
5th Mar 20262:12 pmRNSIssue of Equity
4th Mar 20265:49 pmRNSNet Asset Value(s)
3rd Mar 20262:17 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSTotal Voting Rights
18th Feb 20264:23 pmRNSTransaction in Own Shares
13th Feb 20267:00 amRNSIssue of Equity
6th Feb 202612:01 pmRNSNet Asset Value(s)
4th Feb 20264:34 pmRNSResult of AGM
26th Jan 20264:19 pmRNSOffer for Subscription and Issue of Offer Document
15th Jan 20263:57 pmRNSDividend Declaration
14th Jan 20262:33 pmRNSNet Asset Value(s)
22nd Dec 20254:28 pmRNSPortfolio Update
22nd Dec 20254:28 pmRNSPortfolio Update
10th Dec 20252:24 pmRNSNet Asset Value(s)
5th Dec 20257:12 amRNSDirector Declaration
5th Dec 20257:00 amRNSFinal Results
28th Nov 20251:34 pmRNSPortfolio Update
27th Nov 20257:00 amRNSStatement re Intention to Launch an Offer
6th Nov 20257:00 amRNSNet Asset Value(s)
13th Oct 20254:28 pmRNSNet Asset Value(s)
2nd Sep 202511:22 amRNSNet Asset Value(s)
1st Sep 20259:30 amRNSTotal Voting Rights
14th Aug 20254:57 pmRNSTransaction in Own Shares
12th Aug 20254:13 pmRNSDirector/PDMR Shareholding
12th Aug 202510:27 amRNSIssue of Equity under DRIS
6th Aug 202511:08 amRNSNet Asset Value(s)
1st Aug 20259:02 amRNSTotal Voting Rights
22nd Jul 202510:03 amRNSTransaction in Own Shares
4th Jul 202511:55 amRNSNet Asset Value(s)
1st Jul 20259:33 amRNSTotal Voting Rights
18th Jun 20254:44 pmRNSTransaction in Own Shares
3rd Jun 20251:57 pmRNSNet Asset Value(s)
20th May 20257:00 amRNSHalf-year Report
6th May 20253:24 pmRNSNet Asset Value(s)
15th Apr 20259:48 amRNSIssue of Equity
15th Apr 20257:00 amRNSNet Asset Value(s)
4th Apr 20257:00 amRNSIssue of Equity
1st Apr 20254:23 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.